Biovian shares new insights at BioTalk Berlin
Press Release | Biovian Ltd
SEPTEMBER 20, 2016
Turku, Finland: – Specialist biopharmaceutical contract manufacturer (CMO) Biovian will be a prominent presence at the latest Bio Talk exclusive networking conference in Berlin.
Biovian CEO Dr. Knut Ringbom will represent the company at the event and will be available for in-depth discussions with fellow delegates.
Dr. Ringbom is inviting current and potential partners to contact him before or during the conference to discuss biopharma research or manufacturing projects that require the Finnish contract manufacturer’s distinctive “gene to finished vial” extensive range of end-to-end cGMP manufacturing and development services.
Biovian’s offer includes microbial fermentation, mammalian cell culture, viral vector production, protein purification, formulation, aseptic fill & finish and master cell banking.
“We are pleased to be invited to return to the Bio Talk summit in Berlin,” said Dr. Ringbom. “We found the previous event in 2014 to be very productive event for us, generating plenty of valuable discussions.”
“Once again, I’m looking forward to showing prospective partners how Biovian provides a true ‘one stop shop’ for GMP manufacture of biopharmaceuticals,” , he added.
Biovian Ltd. is a one-stop-shop Contract Manufacturing Organization (CMO) specializing in full-process development and manufacture that extends ‘from gene to finished vial’.
Biovian offers Good Manufacturing Practice compliant (cGMP) services from its 2,700 square meter facilities in Turku, Finland, that are EMA and FDA certified for production of investigational and commercial products.
The CMO has more than a decade’s successful track record in pharmaceutical contract manufacturing ranging over a wide variety of different biopharmaceutical projects. Biovian GMP services include microbial fermentation, mammalian cell culture, viral vector production, protein purification, formulation, aseptic fill & finish, analytical quality control, stability studies and master cell banking. It also offers labeling, packaging, storage and QP release services.
Biovian also provides development services that cover process and analysis.
About BioTalk 2016
BioTalk is a leading biennial conference that brings together some of the most influential senior executives from the world’s pharma and biopharma manufacturing companies.
The summit focuses on how companies and leaders are driving change within their industries to achieve manufacturing excellence.
BioTalk 2016 is a two-day event opening September26 in central Berlin.
The event will include a series of keynote addresses, workshops, discussions and debates. It enables industry leaders to engage with their peers within an exclusive ‘invitation only’ networking environment and discuss shared key challenges in an intimate setting.
Name: Dr. Knut Ringbom, CEO, Biovian Ltd
Tel: +358 2 27488 77